[The activity of immunologic cells from peripheral blood, splenic venous blood and spleen in patients with advanced gastric cancer. A comparative study] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The activity of immunologic cells from peripheral blood, splenic venous blood and spleen in patients with advanced gastric cancer. A comparative study]

Chung Hua Wai Ko Tsa Chih. 1992 Dec;30(12):713-5, 777. Unique Identifier : AIDSLINE MED/94008302
Lin YC; Ruijin Hospital, Shanghai Second Medical University.


Abstract: To elucidate the immunologic function of the spleen in AGC patients, peripheral blood lymphocytes (PBL), splenic venous blood lymphocytes (SVL) and spleen cells (SC) from 40 patients were tested for NK cell activity and T-cell subsets. Significant impairment of NK cell activity, decreased rate of CD+3 and CD+4 cells, declined CD+4/CD+8 ratio, and increased CD+8 cells were noted in SC of AGC patients as compared with PBL of normal subjects. NK cell activity and CD+4 cells of SVL and SC were significantly lower than those of PBL in AGC patients. More significant decline of CD+4/CD+8 cell ratio was found in SVL and SC when compared with PBL in AGC, mainly as a result of the marked decrease of CD+4 cells in SC. In conclusion, AGC tends to weaken the immune status of patients and the immunosuppressive role of the spleen would become more evident with the development of the tumor.
Keywords: Adenocarcinoma/*IMMUNOLOGY Adult Aged Comparative Study CD4-CD8 Ratio English Abstract Female Human Killer Cells, Natural/*IMMUNOLOGY Male Middle Age Spleen/IMMUNOLOGY/PATHOLOGY Stomach Neoplasms/*IMMUNOLOGY T-Lymphocyte Subsets/*IMMUNOLOGY JOURNAL ARTICLEKWDadenocarcinoma/KWDimmunologyadultagedcomparativestudycd4-cd8ratioenglishabstractfemalehumankillercells,natural/KWDimmunologymalemiddleagespleen/immunology/pathologystomachneoplasms/KWDimmunologyt-lymphocytesubsets/KWDimmunologyjournalarticle
940130
M9410820

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .